BR112013031575A2 - composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto. - Google Patents
composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto.Info
- Publication number
- BR112013031575A2 BR112013031575A2 BR112013031575A BR112013031575A BR112013031575A2 BR 112013031575 A2 BR112013031575 A2 BR 112013031575A2 BR 112013031575 A BR112013031575 A BR 112013031575A BR 112013031575 A BR112013031575 A BR 112013031575A BR 112013031575 A2 BR112013031575 A2 BR 112013031575A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- manufacture
- pharmaceutical composition
- main structure
- cyclic peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2011059402 | 2011-06-07 | ||
| EPPCT/EP2011/059402 | 2011-06-07 | ||
| PCT/EP2012/060763 WO2012168336A1 (en) | 2011-06-07 | 2012-06-06 | Beta - hairpin peptidomimetics as cxc4 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013031575A2 true BR112013031575A2 (pt) | 2017-03-21 |
| BR112013031575B1 BR112013031575B1 (pt) | 2021-03-16 |
Family
ID=46208595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013031575-0A BR112013031575B1 (pt) | 2011-06-07 | 2012-06-06 | Composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de um composto, e, processo para a manufatura de um composto |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9079939B2 (pt) |
| JP (1) | JP5957521B2 (pt) |
| KR (1) | KR102091456B1 (pt) |
| CN (1) | CN103703018B (pt) |
| AU (1) | AU2012266355B2 (pt) |
| BR (1) | BR112013031575B1 (pt) |
| CA (1) | CA2838037C (pt) |
| ES (1) | ES2552944T3 (pt) |
| IL (1) | IL229535B (pt) |
| MX (1) | MX343205B (pt) |
| SG (1) | SG195055A1 (pt) |
| WO (1) | WO2012168336A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007079597A1 (en) | 2006-01-16 | 2007-07-19 | Polyphor Ltd. | Template - fixed peptidomimetics with antimicrobial activity |
| DE602007008150D1 (de) | 2007-02-28 | 2010-09-09 | Polyphor Ltd | Templat-fixierte peptidomimetika |
| US9617308B2 (en) * | 2012-06-06 | 2017-04-11 | Polyphor Ag | Beta-hairpin peptidomimetics |
| US20240009266A1 (en) | 2020-11-19 | 2024-01-11 | Polyphor Ag | Pharmaceutical combinations comprising a peptide cxcr4 inhibitor and a taxane for treating cancer |
| WO2022184320A2 (en) | 2021-03-03 | 2022-09-09 | Spexis Ag | Medical use of cyclic peptides |
| WO2023285677A1 (en) | 2021-07-16 | 2023-01-19 | Spexis Ag | Pharmaceutical combinations for treating cancer |
| WO2023285681A1 (en) | 2021-07-16 | 2023-01-19 | Spexis Ag | Pharmaceutical combinations for treating cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995010534A1 (en) | 1993-10-14 | 1995-04-20 | Seikagaku Corporation | Polypeptide and anti-hiv agent prepared therefrom |
| AU2003232253A1 (en) * | 2003-05-02 | 2004-11-23 | Polyphor Ag | Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
| DE602007008150D1 (de) * | 2007-02-28 | 2010-09-09 | Polyphor Ltd | Templat-fixierte peptidomimetika |
| PE20090299A1 (es) * | 2007-05-30 | 2009-03-19 | Lilly Co Eli | Antagonistas cxcr4 de peptido ciclicos |
| US8883720B2 (en) * | 2008-11-26 | 2014-11-11 | Polyphor Ag | Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity |
-
2012
- 2012-06-06 US US14/124,508 patent/US9079939B2/en active Active
- 2012-06-06 AU AU2012266355A patent/AU2012266355B2/en active Active
- 2012-06-06 CA CA2838037A patent/CA2838037C/en active Active
- 2012-06-06 JP JP2014514059A patent/JP5957521B2/ja active Active
- 2012-06-06 SG SG2013085766A patent/SG195055A1/en unknown
- 2012-06-06 WO PCT/EP2012/060763 patent/WO2012168336A1/en active Application Filing
- 2012-06-06 MX MX2013014229A patent/MX343205B/es active IP Right Grant
- 2012-06-06 CN CN201280027783.1A patent/CN103703018B/zh active Active
- 2012-06-06 KR KR1020147000330A patent/KR102091456B1/ko active IP Right Grant
- 2012-06-06 BR BR112013031575-0A patent/BR112013031575B1/pt active IP Right Grant
- 2012-06-06 ES ES12725829.1T patent/ES2552944T3/es active Active
-
2013
- 2013-11-21 IL IL229535A patent/IL229535B/en active IP Right Grant
-
2015
- 2015-06-05 US US14/732,454 patent/US9556231B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20150266924A1 (en) | 2015-09-24 |
| US20140213509A1 (en) | 2014-07-31 |
| CN103703018A (zh) | 2014-04-02 |
| IL229535B (en) | 2018-07-31 |
| JP2014516999A (ja) | 2014-07-17 |
| SG195055A1 (en) | 2013-12-30 |
| WO2012168336A1 (en) | 2012-12-13 |
| US9079939B2 (en) | 2015-07-14 |
| AU2012266355B2 (en) | 2016-06-09 |
| KR102091456B1 (ko) | 2020-03-23 |
| US9556231B2 (en) | 2017-01-31 |
| MX343205B (es) | 2016-10-28 |
| BR112013031575B1 (pt) | 2021-03-16 |
| CN103703018B (zh) | 2016-10-26 |
| IL229535A0 (en) | 2014-01-30 |
| CA2838037A1 (en) | 2012-12-13 |
| AU2012266355A1 (en) | 2013-12-12 |
| ES2552944T3 (es) | 2015-12-03 |
| CA2838037C (en) | 2019-09-17 |
| MX2013014229A (es) | 2014-01-23 |
| NZ618110A (en) | 2014-12-24 |
| JP5957521B2 (ja) | 2016-07-27 |
| KR20140041689A (ko) | 2014-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013030163A2 (pt) | composto, uso cosmético de pelo menos um composto, composição farmacêutica ou cosmética e processo para preparar um composto. | |
| BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112014001255A2 (pt) | composto, uso de um composto, combinação, e, composição farmacêutica | |
| BR112014001346A2 (pt) | composto nanotransportador, método, composto farmacêutico e uso de um composto | |
| BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112013009486A2 (pt) | processo para preparação de formas de dosagem gastrirretentivas multiparticuladas | |
| BR112013031493A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto. | |
| BR112014029530A2 (pt) | compostos, composição farmacêutica e uso de um composto | |
| BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
| BR112014000260A2 (pt) | composto, e, uso de um composto | |
| BR112014010179A8 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
| BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112014003802A2 (pt) | composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento | |
| BR112014030071A2 (pt) | processo para a fabricação de um vapor de dafd, e, composição | |
| BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112013028959A2 (pt) | composto, processo para o preparo de um composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
| BR112015002091A2 (pt) | método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição | |
| BR112013030302A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo | |
| BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
| BR112013031575A2 (pt) | composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto. | |
| BR112014013178A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112015002824A2 (pt) | composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação. | |
| BR112013029206A2 (pt) | composto, e, uso de um composto | |
| BR112014013354A2 (pt) | processo para a preparação de um polímero, composição, composto, e, formulação | |
| BR112013032690A2 (pt) | método para produzir um composto, composto, e, uso do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/06/2012, OBSERVADAS AS CONDICOES LEGAIS. |